NYSE:SOLV - New York Stock Exchange, Inc. - US83444M1018 - Common Stock - Currency: USD
Solventum has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.9%. The stock now trades at $74.24, marking a 24.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Solventum has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.9%. The stock now trades at $74.24, marking a 24.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Mentions: NET
/PRNewswire/ -- Solventum (NYSE: SOLV) Solventum today announced that its AI-powered radiology speech reporting solution, Solventum™ Fluency™ for Imaging, has...
This former Dividend King isn't out of the woods yet.
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025, after the U.S....
/PRNewswire/ -- The T1D Fund, an impact investment fund with a focus on accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D),...
A standalone Honeywell aerospace business could be worth up to $120 billion.
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare...
/PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2024....
3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings.
/PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets...
/PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. This...
/PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. Dr. Egeland is responsible for leading...
/PRNewswire/ -- Solventum (NYSE: SOLV) today announced the launch of the V.A.C.® Peel and Place Dressing, an integrated dressing and drape that can be applied...
/PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett,...
The uncertainty around 3M's business is starting to clear, but there are still problems here that must be considered.
Mentions: MMM